How did Eire grow to be a hotspot for pharmaceutical manufacturing? What are the merchandise that can come out of Flagship’s newest startup centered round “preemptive medication”? And who among the many co-hosts is the perfect singer?
We focus on all that and extra on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. We chat in regards to the latest bounceback in biotech shares, disappointing outcomes from Bristol Myers Squibb’s schizophrenia drug Cobenfy, new allegations about entrepreneur Sam Waksal, and extra.
We additionally deliver on STAT’s European correspondent Drew Joseph to speak in regards to the progress of pharma manufacturing in Eire and the way U.S. tariffs would affect international drug provide.
For extra on Eire and tariffs, go right here; for extra on the restoration in biotech shares, go right here; to be taught extra the disappointing Cobenfy examine, go right here; and to learn in regards to the lawsuit in opposition to Sam Waksal, go right here.
Make sure to enroll in “The Readout LOUD” on Apple Podcasts, Spotify, or wherever you get your podcasts.